HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A randomized multicenter study to determine the efficacy of activity restriction for preterm labor management in patients testing negative for fetal fibronectin.

AbstractOBJECTIVE:
To assess the impact of activity restriction (AR) on the incidence of preterm birth in women treated for preterm labor testing negative for fetal fibronectin (fFN).
STUDY DESIGN:
Women who were diagnosed with preterm labor and tocolyzed with magnesium sulfate were concurrently screened with fFN for the purpose of subsequent management. Included were consenting patients with negative fFN, gestational age 23 0/7-33 6/7 weeks, cervical dilation < or =3 cm, and minimal vaginal bleeding. Patients were randomized to AR or no AR. Primary study outcome was incidence of preterm delivery and interval from randomization to delivery.
RESULTS:
A total of 73 women with negative fFN were randomized (36 with AR, 37 without AR). The overall preterm birth rate was 40%, with 44.4% of patients with AR and 35.1% of patients without AR delivering preterm, p=0.478.
CONCLUSION:
Maternal AR did not impact pregnancy outcome. The incidence of preterm birth in symptomatic women testing fFN negative was higher than previously reported.
AuthorsJohn P Elliott, Hugh S Miller, Suzanne Coleman, Debbie Rhea, Diana Abril, Karen Hallbauer, Niki B Istwan, Gary J Stanziano
JournalJournal of perinatology : official journal of the California Perinatal Association (J Perinatol) Vol. 25 Issue 10 Pg. 626-30 (Oct 2005) ISSN: 0743-8346 [Print] United States
PMID16107874 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • FFN protein, human
  • Fibronectins
  • Glycoproteins
  • Tocolytic Agents
  • Magnesium Sulfate
Topics
  • Adult
  • Bed Rest
  • Female
  • Fibronectins (analysis)
  • Gestational Age
  • Glycoproteins (analysis)
  • Humans
  • Infant, Newborn
  • Magnesium Sulfate (administration & dosage)
  • Obstetric Labor, Premature (prevention & control)
  • Pregnancy
  • Pregnancy Outcome
  • Prospective Studies
  • Tocolytic Agents (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: